Onychopathy in a patient with fetal hydantoin syndrome

Area of Science:

• Pharmacology
• Teratology
• Developmental Pediatrics

Background:

• Hydantoin is an anticonvulsant medication with known side effects.
• A teratogenic potential for hydantoin has been previously suggested.
• Fetal hydantoin syndrome encompasses various birth defects in infants exposed to hydantoin in utero.

Purpose of the Study:

• To report a case of fetal hydantoin syndrome.
• To describe onychopathy as a potential manifestation of this syndrome.
• To contribute to the understanding of hydantoin's teratogenic effects.

Main Methods:

• Case report of a patient diagnosed with fetal hydantoin syndrome.
• Clinical observation and documentation of patient's symptoms, focusing on onychopathy.
• Review of relevant medical literature on hydantoin teratogenicity.

Main Results:

• The patient presented with onychopathy, a nail disorder.
• Onychopathy was considered a monosymptomatic or mild form of fetal hydantoin syndrome.
• This presentation expands the spectrum of known fetal hydantoin syndrome manifestations.

Conclusions:

• Onychopathy can be a presenting sign of fetal hydantoin syndrome.
• Early recognition of mild forms is crucial for managing potential developmental issues.
• Further research is needed to fully elucidate the teratogenic profile of hydantoin.